Literature DB >> 34088317

Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.

Jiajia Wang1, Xinjing Yang2, Yongsheng Li3, Jian-An Huang1, Junhong Jiang4,5, Nan Su6.   

Abstract

BACKGROUND: To date, specific cytokines associated with development of acute respiratory distress syndrome (ARDS) and extrapulmonary multiple organ dysfunction (MOD) in COVID-19 patients have not been systematically described. We determined the levels of inflammatory cytokines in patients with COVID-19 and their relationships with ARDS and extrapulmonary MOD.
METHODS: The clinical and laboratory data of 94 COVID-19 patients with and without ARDS were analyzed. The levels of inflammatory cytokines (interleukin 6 [IL-6], IL-8, IL-10, and tumor necrosis factor α [TNF-α]) were measured on days 1, 3, and 5 following admission. Seventeen healthy volunteers were recruited as controls. Correlations in the levels of inflammatory cytokines with clinical and laboratory variables were analyzed, furthermore, we also explored the relationships of different cytokines with ARDS and extrapulmonary MOD.
RESULTS: The ARDS group had higher serum levels of all 4 inflammatory cytokines than the controls, and these levels steadily increased after admission. The ARDS group also had higher levels of IL-6, IL-8, and IL-10 than the non-ARDS group, and the levels of these cytokines correlated significantly with coagulation parameters and disseminated intravascular coagulation (DIC). The levels of IL-6 and TNF-α correlated with the levels of creatinine and urea nitrogen, and were also higher in ARDS patients with acute kidney injury (AKI). All 4 inflammatory cytokines had negative correlations with PaO2/FiO2. IL-6, IL-8, and TNF-α had positive correlations with the APACHE-II score. Relative to survivors, non-survivors had higher levels of IL-6 and IL-10 at admission, and increasing levels over time.
CONCLUSIONS: The cytokine storm apparently contributed to the development of ARDS and extrapulmonary MOD in COVID-19 patients. The levels of IL-6, IL-8, and IL-10 correlated with DIC, and the levels of IL-6 and TNF-α were associated with AKI. Relative to survivors, patients who died within 28 days had increased levels of IL-6 and IL-10.

Entities:  

Keywords:  Acute respiratory distress syndrome; COVID-19; Disseminated intravascular coagulation; Inflammatory cytokine; Multiple-organ dysfunction; SARS-CoV-2

Year:  2021        PMID: 34088317     DOI: 10.1186/s12985-021-01588-y

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  39 in total

1.  Endolymphatic-mastoid shunt operation: results of the 24 cases and revision surgery with the silastic sheet.

Authors:  K Gyo; N Yanagihara
Journal:  Auris Nasus Larynx       Date:  1982       Impact factor: 1.863

2.  Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis.

Authors:  P Loisa; T Rinne; S Laine; M Hurme; S Kaukinen
Journal:  Acta Anaesthesiol Scand       Date:  2003-03       Impact factor: 2.105

3.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm?

Authors:  Paola Rizzo; Francesco Vieceli Dalla Sega; Francesca Fortini; Luisa Marracino; Claudio Rapezzi; Roberto Ferrari
Journal:  Basic Res Cardiol       Date:  2020-04-09       Impact factor: 17.165

5.  COVID-19 cytokine storm: the interplay between inflammation and coagulation.

Authors:  Ricardo J Jose; Ari Manuel
Journal:  Lancet Respir Med       Date:  2020-04-27       Impact factor: 30.700

6.  Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.

Authors:  Jing Liu; Sumeng Li; Jia Liu; Boyun Liang; Xiaobei Wang; Hua Wang; Wei Li; Qiaoxia Tong; Jianhua Yi; Lei Zhao; Lijuan Xiong; Chunxia Guo; Jin Tian; Jinzhuo Luo; Jinghong Yao; Ran Pang; Hui Shen; Cheng Peng; Ting Liu; Qian Zhang; Jun Wu; Ling Xu; Sihong Lu; Baoju Wang; Zhihong Weng; Chunrong Han; Huabing Zhu; Ruxia Zhou; Helong Zhou; Xiliu Chen; Pian Ye; Bin Zhu; Lu Wang; Wenqing Zhou; Shengsong He; Yongwen He; Shenghua Jie; Ping Wei; Jianao Zhang; Yinping Lu; Weixian Wang; Li Zhang; Ling Li; Fengqin Zhou; Jun Wang; Ulf Dittmer; Mengji Lu; Yu Hu; Dongliang Yang; Xin Zheng
Journal:  EBioMedicine       Date:  2020-04-18       Impact factor: 8.143

7.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors:  Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

Review 8.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.

Authors:  Rudragouda Channappanavar; Stanley Perlman
Journal:  Semin Immunopathol       Date:  2017-05-02       Impact factor: 9.623

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  15 in total

1.  Multi-drug Treatment for COVID-19-induced Acute Respiratory Distress Syndrome

Authors:  Masashi Ohe
Journal:  Turk J Pharm Sci       Date:  2022-02-28

2.  Comparison of acute respiratory distress syndrome in patients with COVID-19 and influenza A (H7N9) virus infection.

Authors:  Ling Ding; Yikun Chen; Nan Su; Xizhen Xu; Jingping Yin; Jun Qiu; Jiajia Wang; Dong Zheng
Journal:  Int J Infect Dis       Date:  2022-07-03       Impact factor: 12.074

3.  Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice.

Authors:  Ana C Puhl; Giovanni F Gomes; Samara Damasceno; Ethan J Fritch; James A Levi; Nicole J Johnson; Frank Scholle; Lakshmanane Premkumar; Brett L Hurst; Felipe LeeMontiel; Flavio P Veras; Sabrina S Batah; Alexandre T Fabro; Nathaniel J Moorman; Boyd L Yount; Rebekah Dickmander; Ralph Baric; Kenneth H Pearce; Fernando Q Cunha; José C Alves-Filho; Thiago M Cunha; Sean Ekins
Journal:  bioRxiv       Date:  2021-12-20

4.  Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.

Authors:  Takeshi Ebihara; Hisatake Matsumoto; Tsunehiro Matsubara; Yuki Togami; Shunichiro Nakao; Hiroshi Matsuura; Takashi Kojima; Fuminori Sugihara; Daisuke Okuzaki; Haruhiko Hirata; Hitoshi Yamamura; Hiroshi Ogura
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

5.  Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.

Authors:  Lowell Ling; Zigui Chen; Grace Lui; Chun Kwok Wong; Wai Tat Wong; Rita W Y Ng; Eugene Y K Tso; Kitty S C Fung; Veronica Chan; Apple C M Yeung; David S C Hui; Paul K S Chan
Journal:  Front Immunol       Date:  2021-12-06       Impact factor: 7.561

6.  Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia.

Authors:  Guiying Dong; Jianbo Yu; Weibo Gao; Wei Guo; Jihong Zhu; Tianbing Wang
Journal:  Ann Hematol       Date:  2021-12-04       Impact factor: 3.673

Review 7.  Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities.

Authors:  Hamed Fouladseresht; Atefe Ghamar Talepoor; Nahid Eskandari; Marzieh Norouzian; Behrooz Ghezelbash; Mohammad Reza Beyranvand; Seyed Aria Nejadghaderi; Kristin Carson-Chahhoud; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

8.  TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19.

Authors:  Ingrid Fricke-Galindo; Ivette Buendía-Roldán; Andy Ruiz; Yadira Palacios; Gloria Pérez-Rubio; Rafael de Jesus Hernández-Zenteno; Felipe Reyes-Melendres; Armando Zazueta-Márquez; Aimé Alarcón-Dionet; Javier Guzmán-Vargas; Omar Andrés Bravo-Gutiérrez; Teresa Quintero-Puerta; Ilse Adriana Gutiérrez-Pérez; Karol J Nava-Quiroz; José Luis Bañuelos-Flores; Mayra Mejía; Jorge Rojas-Serrano; Espiridión Ramos-Martínez; Iris Paola Guzmán-Guzmán; Leslie Chávez-Galán; Ramcés Falfán-Valencia
Journal:  J Infect Dis       Date:  2022-09-13       Impact factor: 7.759

9.  Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019.

Authors:  Wasan W Al-Bassam; Ibtihal A Al-Karaawi; Inas K Sharquie; Ali H Ad'hiah
Journal:  J Med Virol       Date:  2022-04-14       Impact factor: 20.693

10.  Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology.

Authors:  Amelia Barilli; Rossana Visigalli; Francesca Ferrari; Massimiliano G Bianchi; Valeria Dall'Asta; Bianca Maria Rotoli
Journal:  Biomedicines       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.